Phio Pharmaceuticals Corp SEC filings PHIO
Phio Pharmaceuticals Corp has 892 filings in SEC EDGAR's recent list, going back to Oct 25, 2011. Its latest annual report, Form ARS, was filed on Aug 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Aug 14, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Jul 30, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | May 8, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Jun 9, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 29, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 22, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 27, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 26, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 30, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 30, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 30, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 28, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 29, 2013 | Dec 31, 2012 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PHIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- King Of Prussia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1533040
- Former names
- RXi Pharmaceuticals Corp (until Nov 14, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.